Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cambridge Innovation Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 90
Average round size
info
The average size of a deal this fund participated in
$34M
Portfolio companies 43
Rounds per year 8.18
Lead investments 16
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.52
Exits 3
Key employees 5
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Therapeutics
  • Information Technology
Summary

In 2013 was created Cambridge Innovation Capital, which is appeared as VC. The main office of represented VC is situated in the Cambridge. The company was established in Europe in United Kingdom.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cambridge Innovation Capital, startups are often financed by Parkwalk Advisors, Cambridge Angels group, University of Cambridge Enterprise. The meaningful sponsors for the fund in investment in the same round are Amadeus Capital Partners, IQ Capital, Escala Capital. In the next rounds fund is usually obtained by Martlet, Innovate UK, Amadeus Capital Partners.

The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Origami Energy, Gyroscope Therapeutics, Carrick Therapeutics. We can highlight the next thriving fund investment areas, such as Information Technology, Medical Device. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

We also calculated 10 valuable employees in our database.

This Cambridge Innovation Capital works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 24 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2016. The fund is generally included in 7-12 deals every year. The typical startup value when the investment from Cambridge Innovation Capital is 100-500 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cambridge Innovation Capital:
Typical Co-investors
Cambridge Innovation Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cambridge Innovation Capital:

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Epitopea

Biotechnology
Life Science
Therapeutics
24 Oct 2024 Cambridge, Cambridgeshire, United Kingdom

Nuclera

Biotechnology
Industrial Engineering
Life Science
Pharmaceutical
15 Oct 2024 Cambridge, Cambridgeshire, United Kingdom

Riverlane

Computer
Information Technology
Quantum Computing
Software
$75M06 Aug 2024 Cambridge, England, United Kingdom

Phosphor AI

$2M04 Jan 2024 Hong Kong, Hong Kong, China

T-Therapeutics

Biotechnology
Health Care
Medical
$65M15 Nov 2023 Cambridge, Cambridgeshire, United Kingdom

Riverlane

Computer
Information Technology
Quantum Computing
Software
$20M24 Apr 2023 Cambridge, England, United Kingdom

Complement Therapeutics

Biotechnology
Medical
$84M17 Apr 2023 London, England, United Kingdom

Mosaic Therapeutics

Medical
Therapeutics
$28M04 Apr 2023 Cambridge, Cambridgeshire, United Kingdom

Seldon

Artificial Intelligence
Machine Learning
Open Source
SaaS
$20M16 Mar 2023 London, England, United Kingdom
News
PetMedix Raises $37M in Series B Funding

– PetMedix, a Cambridge UK-based animal health company, raised $37M in Series B funding.
– The round was led by Tencent and Kyoritsu Holdings with participation from Digitalis Ventures, Parkwalk Advisors and Cambridge Innovation Capital.
– The company intends to use the funds to advance its innovative pipeline through clinical development.

CMR Surgical Raises $600M in Series D Funding

– CMR Surgical is a Cambridge UK-based surgical robotic company.
– Series D $600M round was led by SoftBank Vision Fund 2 with participation from Ally Bridge Group, new investors RPMI Railpen, Tencent and Chimera, and existing investors LGT and its affiliate impact investing platform Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare.
– The investment will be used for the global commercialization of Versius and further develop the company’s digital ecosystem.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cambridge Innovation Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 90
Average round size 34M
Rounds per year 8.18
Peak activity year 2016
Lead investments 16
Follow on index 0.52
Exits 3
Group Appearance index 0.84

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Epitopea

Biotechnology
Life Science
Therapeutics
24 Oct 2024 Cambridge, Cambridgeshire, United Kingdom

Nuclera

Biotechnology
Industrial Engineering
Life Science
Pharmaceutical
15 Oct 2024 Cambridge, Cambridgeshire, United Kingdom

Riverlane

Computer
Information Technology
Quantum Computing
Software
$75M06 Aug 2024 Cambridge, England, United Kingdom

Phosphor AI

$2M04 Jan 2024 Hong Kong, Hong Kong, China

T-Therapeutics

Biotechnology
Health Care
Medical
$65M15 Nov 2023 Cambridge, Cambridgeshire, United Kingdom

Riverlane

Computer
Information Technology
Quantum Computing
Software
$20M24 Apr 2023 Cambridge, England, United Kingdom

Complement Therapeutics

Biotechnology
Medical
$84M17 Apr 2023 London, England, United Kingdom

Mosaic Therapeutics

Medical
Therapeutics
$28M04 Apr 2023 Cambridge, Cambridgeshire, United Kingdom

Seldon

Artificial Intelligence
Machine Learning
Open Source
SaaS
$20M16 Mar 2023 London, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: